Fluoxetine discontinuation in elderly dysthymic patients.
A group of 23 elderly outpatients with dysthymic disorder participated in a 13-week fluoxetine trial. Twelve responders received open continuation treatment and subsequently discontinued fluoxetine (mean: 32 weeks on medication). During the 24 weeks after discontinuation, 6 of the 12 patients relapsed. Clinical features, dose, and duration of fluoxetine treatment were not predictive of relapse. The 50% relapse rate in this small sample is lower than that reported in young adult dysthymic patients but is high enough to warrant clinical caution.